Refresh
Exchange Announcement • 03 May 2024 20:30
Exchange Announcement • 03 May 2024 20:00
Exchange Announcement • 11 Mar 2024 19:30
Exchange Announcement • 07 Mar 2024 05:20
Exchange Announcement • 14 Feb 2024 20:35
ENTITY
Sonnet BioTherapeutics Holding (SONN US)
Sonnet BioTherapeutics Holding (SONN US)
Health Care • United States
Sonnet BioTherapeutics Holdings, Inc. operates as a clinical stage biotechnology company. The Company develops fully human albumin binding technology that helps the development of innovative targeted biologic drugs with enhanced single-or bi-specific mechanisms. Sonnet BioTherapeutics Holdings serves customers in the United States.
more
x